An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Vapotherm, Inc. (NYSE: VAPO) will release its financial results for Q3 2021 on November 3, 2021, after market close. The management team will hold a conference call at 4:30 p.m. ET to discuss results and recent business developments. U.S. callers can reach the call at (888) 330-2022, and international callers can dial +1 (646) 960-0690. The conference call will also be available via live webcast on the company's website, with a replay accessible for 90 days. Vapotherm focuses on non-invasive respiratory therapy for various breathing disorders.
Positive
None.
Negative
None.
EXETER, N.H.--(BUSINESS WIRE)--
Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products which are used to treat patients of all ages suffering from respiratory distress, today announced that it will release financial results for the third quarter of 2021 after the close of trading on Wednesday, November 3, 2021. Vapotherm’s management team will host a conference call beginning at 4:30 p.m. ET to discuss the financial results and recent business developments.
To listen to the conference call on your telephone, please dial (888) 330-2022 for U.S. callers, or +1 (646) 960-0690 for international callers, approximately ten minutes prior to the start time and reference conference code 6585549. To listen to a live webcast, please visit the Investors section of the Vapotherm website at: http://investors.vapotherm.com/events-and-presentations/events. The webcast replay will be available on the Vapotherm website for 90 days following completion of the call. A replay of this conference call will be available by telephone through November 10, 2021, by dialing (800) 770-2030 in the U.S. or +1 (647) 362-9199 outside of the U.S. The replay access code is 6585549.
About Vapotherm
Vapotherm, Inc. (NYSE: VAPO) is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA. The company develops innovative, comfortable, non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. Vapotherm is focused on the development and commercialization of its proprietary Vapotherm high velocity therapy products which are used to treat patients of all ages suffering from respiratory distress. Over 3.0 million patients have been treated with the use of Vapotherm high velocity therapy systems. For more information, visit www.vapotherm.com.
Vapotherm high velocity therapy is mask-free noninvasive ventilatory support and is a front-line tool for relieving respiratory distress—including hypercapnia, hypoxemia, and dyspnea. It allows for the fast, safe treatment of undifferentiated respiratory distress with one tool. The Precision Flow system’s mask-free interface delivers optimally conditioned breathing gases, making it comfortable for patients and reducing the risks and care complexities associated with mask therapies. While being treated, patients can talk, eat, drink and take oral medication.
Website Information
Vapotherm routinely posts important information for investors on the Investor Relations section of its website, http://investors.vapotherm.com/. Vapotherm intends to use this website as a means of disclosing material, non-public information and for complying with Vapotherm’s disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investor Relations section of Vapotherm’s website, in addition to following Vapotherm’s press releases, Securities and Exchange Commission (“SEC”) filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, Vapotherm’s website is not incorporated by reference into, and is not a part of, this document.
Investor Relations Contact:
Mark Klausner or Mike Vallie, Westwicke, an ICR Company, ir@vtherm.com, +1 (603) 658-0011
Source: Vapotherm, Inc.
FAQ
When will Vapotherm release its Q3 2021 financial results?
Vapotherm will release its Q3 2021 financial results on November 3, 2021, after market close.
What time is the Vapotherm Q3 2021 conference call?
The conference call for Vapotherm's Q3 2021 results will be held at 4:30 p.m. ET on November 3, 2021.
How can I listen to Vapotherm's Q3 2021 conference call?
You can listen to Vapotherm's Q3 2021 conference call by dialing (888) 330-2022 for U.S. callers or +1 (646) 960-0690 for international callers. A live webcast is also available on their website.
How long will the Vapotherm conference call replay be available?
The replay of Vapotherm's conference call will be available until November 10, 2021.
What is Vapotherm's focus in respiratory therapy?
Vapotherm focuses on developing advanced non-invasive respiratory therapies for patients with chronic or acute breathing disorders.
